Management of Chemotherapy-Induced Cardiotoxicity in Female
... • Routine surveillance imaging may be offered during treatment in asymptomatic patients considered to be at increased risk (Recommendation 1.1) of developing cardiac dysfunction. In these individuals, echocardiography is the surveillance imaging modality of choice that should be offered. Frequency o ...
... • Routine surveillance imaging may be offered during treatment in asymptomatic patients considered to be at increased risk (Recommendation 1.1) of developing cardiac dysfunction. In these individuals, echocardiography is the surveillance imaging modality of choice that should be offered. Frequency o ...
Drugs treating congestive heart failure
... unable to pump sufficient blood to meet the needs of body. CHF can be increased workload imposed on the heart. CHF is accompanied by abnormal increases in blood volume and interstitial fluid; the heart, veins, and capillaries are therefore generally dilated with blood. Hence the term “congestive(充血性 ...
... unable to pump sufficient blood to meet the needs of body. CHF can be increased workload imposed on the heart. CHF is accompanied by abnormal increases in blood volume and interstitial fluid; the heart, veins, and capillaries are therefore generally dilated with blood. Hence the term “congestive(充血性 ...
4 Decisions Driving Growth - Croydon Health Services NHS Trust
... for others) • Specialist review by Cardiologist and Heart Failure Nurse, with echo at the same appointment, thereby providing early confirmation of diagnosis ...
... for others) • Specialist review by Cardiologist and Heart Failure Nurse, with echo at the same appointment, thereby providing early confirmation of diagnosis ...
Who`s at Risk for SCD_Berul
... Because risk stratification is still being refined, it is often recommended that most LQTS patients be treated with -adrenergic blocking medications, but a diagnostic challenge is deciding who needs more specific or aggressive therapies. Interventions for LQTS include implantation of a permanent pa ...
... Because risk stratification is still being refined, it is often recommended that most LQTS patients be treated with -adrenergic blocking medications, but a diagnostic challenge is deciding who needs more specific or aggressive therapies. Interventions for LQTS include implantation of a permanent pa ...
Effect of milrinone on short-term outcome of patients with myocardial
... treated with milrinone, which agrees with the report by Levy et al. [22] which suggested that milrinone is an alternative to other inotropic drugs. In our study, pre-operative LVEF was significantly lower in the milrinone group, while there was no difference between post-operative LVEFs in the two g ...
... treated with milrinone, which agrees with the report by Levy et al. [22] which suggested that milrinone is an alternative to other inotropic drugs. In our study, pre-operative LVEF was significantly lower in the milrinone group, while there was no difference between post-operative LVEFs in the two g ...
PDF - Revista Colombiana de Anestesiología
... The patient stayed in the ICU for one month until complete recovery of the effects from total body ischemia and the reperfusion phenomenon leading to ischemic liver failure (creatinine 6.0) and ischemic liver failure that required hemodynamic support with norepinephrine for 4 days, mechanical ventil ...
... The patient stayed in the ICU for one month until complete recovery of the effects from total body ischemia and the reperfusion phenomenon leading to ischemic liver failure (creatinine 6.0) and ischemic liver failure that required hemodynamic support with norepinephrine for 4 days, mechanical ventil ...
Heart and Circulatory System?Arrhythmia (Irregular Heartbeat)
... A resting heart rate of more than 100 beats per minute (rapid ventricular response) or episodes of heart rate greater than 130140 with minimal exertion will also preclude certification for any class of medical certificate. Most antiarrhythmic medications are acceptable for controlling the ventricul ...
... A resting heart rate of more than 100 beats per minute (rapid ventricular response) or episodes of heart rate greater than 130140 with minimal exertion will also preclude certification for any class of medical certificate. Most antiarrhythmic medications are acceptable for controlling the ventricul ...
2010 Focused Update of ESC Guidelines on
... left ventricular ejection fraction left ventricular stroke volume index left ventricular end-systolic volume 6 min walk test not applicable National Institutes of Health not significant New York Heart Association optimal medical therapy peak oxygen consumption quality of life right bundle branch blo ...
... left ventricular ejection fraction left ventricular stroke volume index left ventricular end-systolic volume 6 min walk test not applicable National Institutes of Health not significant New York Heart Association optimal medical therapy peak oxygen consumption quality of life right bundle branch blo ...
Arrhythmias 3
... Variable impulse conduction through the AVN Irregularly irregular rhythm Most common arrhythmia. 10% of population >80 years old. Significant morbidity due to thromboembolic disease ...
... Variable impulse conduction through the AVN Irregularly irregular rhythm Most common arrhythmia. 10% of population >80 years old. Significant morbidity due to thromboembolic disease ...
Sudden Cardiac Arrest (SCA)
... Usually caused by ventricular fibrillation (VF) − An abnormality in the heart's electrical system which causes the heart to quiver and blood flow to the body and brain to stop. ...
... Usually caused by ventricular fibrillation (VF) − An abnormality in the heart's electrical system which causes the heart to quiver and blood flow to the body and brain to stop. ...
Evaluation of the Patient Suspected of Having Underlying Arrhythmias
... Every QRS complex is preceded by a P wave and every P wave must be followed by a QRS (the opposite occurs if there is second or third degree AV block). The P wave morphology and axis must be normal and PR interval will usually be normal for that age ...
... Every QRS complex is preceded by a P wave and every P wave must be followed by a QRS (the opposite occurs if there is second or third degree AV block). The P wave morphology and axis must be normal and PR interval will usually be normal for that age ...
Dynamics of Heart Rate Turbulence
... favor of a prevailing sympathetic tone, so that the baroreflex sensitivity may be attenuated. ...
... favor of a prevailing sympathetic tone, so that the baroreflex sensitivity may be attenuated. ...
Phase I Clinical Trial of Autologous Stem Cell–Sheet
... available, were enrolled. Scaffold-free cell sheets of 3 to 99108 cells derived from autologous muscle were transplanted over the LV free wall via left thoracotomy, without additional interventional treatments. There were no procedure-related major complications during follow-up. The majority of the ...
... available, were enrolled. Scaffold-free cell sheets of 3 to 99108 cells derived from autologous muscle were transplanted over the LV free wall via left thoracotomy, without additional interventional treatments. There were no procedure-related major complications during follow-up. The majority of the ...
Document
... In order to improve the existing incremental principle of determining the cardiac and respiratory rhythm synchronization (CRS) range the ‘quick technique’ of determining the index of regulatory-adaptive status (IRAS) of the human body has been proposed. In order to reduce the number of samples we pr ...
... In order to improve the existing incremental principle of determining the cardiac and respiratory rhythm synchronization (CRS) range the ‘quick technique’ of determining the index of regulatory-adaptive status (IRAS) of the human body has been proposed. In order to reduce the number of samples we pr ...
danish heart failure database and regional clinical quality
... 0.74; 95% confidence interval: 0.64 to 0.86) and the risk of hospital admissions (relative risk: 0.82; 95% confidence interval: 0.70 to 0.96) • There was no significant effect on total mortality, myocardial infarction, or revascularization • Higher levels of health related quality of life after CR. ...
... 0.74; 95% confidence interval: 0.64 to 0.86) and the risk of hospital admissions (relative risk: 0.82; 95% confidence interval: 0.70 to 0.96) • There was no significant effect on total mortality, myocardial infarction, or revascularization • Higher levels of health related quality of life after CR. ...
Curriculum Vitae
... transplant surgery. He continues to operate on children through his charity, The Chain of Hope. In 2006 he briefly came out of retirement to advise on a complicated procedure which required removing a transplant heart from a patient whose own heart had recovered. The patient's original heart had not ...
... transplant surgery. He continues to operate on children through his charity, The Chain of Hope. In 2006 he briefly came out of retirement to advise on a complicated procedure which required removing a transplant heart from a patient whose own heart had recovered. The patient's original heart had not ...
SCIOS SPEAKERS BUREAU HEALTH CARE COMPLIANCE …
... • Survival is improving with AMI* and revascularization • HF not treated appropriately during hospitalization • Patients do not adhere to diet and drugs ...
... • Survival is improving with AMI* and revascularization • HF not treated appropriately during hospitalization • Patients do not adhere to diet and drugs ...
Dilated Cardiomyopathy (DCM) - Cincinnati Children`s Hospital
... that can be caused by a viral illness. These viruses are the same illnesses that may cause a common cold but in some individuals can lead to a heart muscle problem. Other causes of DCM include chemotherapy exposure and metabolic diseases. In many cases, the cause of DCM in an individual cannot be id ...
... that can be caused by a viral illness. These viruses are the same illnesses that may cause a common cold but in some individuals can lead to a heart muscle problem. Other causes of DCM include chemotherapy exposure and metabolic diseases. In many cases, the cause of DCM in an individual cannot be id ...
Cardiovascular Lecture-2
... have the 2 important roles of forming the conduction system of the heart and acting as pacemakers within that system. Because it has the fastest rate of depolarization, the normal pacemaker of the heart is the sinoatrial (SA) node, located in the ...
... have the 2 important roles of forming the conduction system of the heart and acting as pacemakers within that system. Because it has the fastest rate of depolarization, the normal pacemaker of the heart is the sinoatrial (SA) node, located in the ...
Patent Ductus Arteriosus Patent Ductus Arteriosus
... the lungs since the lungs are not used during development in the uterus. At birth this vessel should close within hours, directing blood to flow to the lungs. Pets diagnosed with a PDA have a greater than 50% mortality rate by one year of age if left untreated. PDA is the most frequently diagnosed c ...
... the lungs since the lungs are not used during development in the uterus. At birth this vessel should close within hours, directing blood to flow to the lungs. Pets diagnosed with a PDA have a greater than 50% mortality rate by one year of age if left untreated. PDA is the most frequently diagnosed c ...
united states securities and exchange commission - corporate
... In the PRESERVATION I trial, the primary endpoint is enlargement in the end-diastolic volume at 6 months after heart attack in subjects who received BCM compared to those who received saline placebo. Change in end-systolic volume at 6 months after heart attack is another endpoint. Based on the histo ...
... In the PRESERVATION I trial, the primary endpoint is enlargement in the end-diastolic volume at 6 months after heart attack in subjects who received BCM compared to those who received saline placebo. Change in end-systolic volume at 6 months after heart attack is another endpoint. Based on the histo ...
anaesthesia for beating heart surgery
... cardiac pump function, and acute intra-operative myocardial ischemia. The team must be prepared for conversion to CPB in case of sustained ventricular fibrillation or cardiovascular collapse ...
... cardiac pump function, and acute intra-operative myocardial ischemia. The team must be prepared for conversion to CPB in case of sustained ventricular fibrillation or cardiovascular collapse ...
Ch. 13
... o Atrial contraction precedes ventricle contraction Spread of Excitation between Cells (Figure 13.9): APs generated from SA node travel to adjacent cells via gap junction. Initiation and Conduction of an Impulse during a Heartbeat (Figure 13.10) o SA node initiates pacemaker potential o Atrial excit ...
... o Atrial contraction precedes ventricle contraction Spread of Excitation between Cells (Figure 13.9): APs generated from SA node travel to adjacent cells via gap junction. Initiation and Conduction of an Impulse during a Heartbeat (Figure 13.10) o SA node initiates pacemaker potential o Atrial excit ...
A Practical Approach to the Perioperative Management of Heart
... events following non-cardiac surgery [32]. Class: The New York Heart Association (NYHA) functional classification correlates with quality of life and survival. Because the paramount symptom of HF is dyspnea on exertion, the NYHA class stratifies patients based on the symptom severity as described in ...
... events following non-cardiac surgery [32]. Class: The New York Heart Association (NYHA) functional classification correlates with quality of life and survival. Because the paramount symptom of HF is dyspnea on exertion, the NYHA class stratifies patients based on the symptom severity as described in ...
A Practical Approach to the Perioperative Management of Heart
... events following non-cardiac surgery [32]. Class: The New York Heart Association (NYHA) functional classification correlates with quality of life and survival. Because the paramount symptom of HF is dyspnea on exertion, the NYHA class stratifies patients based on the symptom severity as described in ...
... events following non-cardiac surgery [32]. Class: The New York Heart Association (NYHA) functional classification correlates with quality of life and survival. Because the paramount symptom of HF is dyspnea on exertion, the NYHA class stratifies patients based on the symptom severity as described in ...
Cardiac contractility modulation
.jpg?width=300)
Cardiac contractility modulation (CCM) is a treatment for patients with moderate to severe left ventricular systolic heart failure (NYHA class II–IV). The short- and long-term use of this therapy enhances both the strength of ventricular contraction and the heart’s pumping capacity. The CCM mechanism is based on stimulation of the cardiac muscle by non-excitatory electrical signals (NES). CCM treatment is delivered by a pacemaker-like device that applies the NES, adjusted to and synchronized with the electrical action in the cardiac cycle.In CCM therapy, electrical stimulation is applied to the cardiac muscle during the absolute refractory period. In this phase of the cardiac cycle, electrical signals cannot trigger new cardiac muscle contractions, hence this type of stimulation is known as a non-excitatory stimulation. However, the electrical CCM signals increase the influx of calcium ions into the cardiac muscle cells (cardiomyocytes). In contrast to other electrical stimulation treatments for heart failure, such as pacemaker therapy or implantable cardioverter defibrillators (ICD), CCM does not affect the cardiac rhythm directly. Rather, the aim is to enhance the heart’s natural contraction (the native cardiac contractility) sustainably over long periods of time. Furthermore, unlike most interventions that increase cardiac contractility, CCM is not associated with an unfavorable increase in oxygen demand by the heart (measured in terms of Myocardial Oxygen Consumption or MVO2). This may be explained by the beneficial effect CCM has in improving cardiac efficiency. A meta-analysis in 2014 and an overview of device-based treatment options in heart failure in 2013 concluded that CCM treatment is safe, that it is generally beneficial to patients and that CCM treatment increases the exercise tolerance (ET) and quality of life (QoL) of patients. Furthermore, preliminary long-term survival data shows that CCM is associated with lower long-term mortality in heart failure patients when compared with expected rates among similar patients not treated with CCM.